Incidence and prevalence are two foundational measures in epidemiology that answer different questions about how a condition affects a population. Incidence measures how many new cases of a condition arise in a population over a period of time, capturing the rate at which cases occur. Prevalence measures how many cases exist in a population at a point in time or over a defined period, capturing the burden present. Confusing the two leads to serious misinterpretation, so the distinction is a methodological essential rather than a matter of terminology.
Both measures rest on the same underlying ideas of a case, a population at risk, and a time reference, but they assemble those ingredients differently. Getting the definitions right is the first step to choosing the correct measure for a given research or planning question.
How incidence is calculated
Incidence quantifies new cases relative to a population at risk over time, and it comes in two common forms. Cumulative incidence divides the number of new cases by the number of people at risk at the start of the period, giving a proportion that approximates the average risk of developing the condition over that period. Incidence rate, sometimes called incidence density, divides new cases by the total person-time at risk, which accounts for individuals being observed for different lengths of time and for people entering or leaving the population. Both forms require defining the population at risk precisely, excluding those who already have the condition, and stating the observation window clearly. The person-time approach is particularly useful in studies where people are followed for varying durations, because each individual contributes time at risk only for as long as they are observed and remain capable of developing the condition. Expressing the result, for example, as cases per 1,000 person-years makes the time dimension explicit and allows fair comparison between groups followed for different lengths of time.
How prevalence is calculated
Prevalence divides the number of existing cases by the total population, counting everyone who currently has the condition regardless of when it began. Point prevalence refers to a single point in time, answering how many cases exist right now, while period prevalence covers a defined interval and counts anyone who had the condition at any time during that interval. Because prevalence includes both long-standing and recently arisen cases, it reflects the accumulated stock of cases in the population rather than the flow of new ones.
Incidence and prevalence compared
| Feature | Incidence | Prevalence |
|---|---|---|
| What it counts | New cases arising | Existing cases present |
| Time element | Over a period (flow) | At a point or period (stock) |
| Denominator | Population at risk or person-time | Total population |
| Best for | Studying causes and risk | Describing burden and planning |
Data sources and case ascertainment
Both measures depend on how reliably cases are identified, a process known as case ascertainment. Cases may be captured through disease registers, routine health records, notification systems for certain conditions, or purpose-designed studies, and each source has its own coverage and biases. Incidence is especially sensitive to the timing and completeness of detection, because it counts new cases within a defined window; if detection is delayed or incomplete, new cases may be missed or assigned to the wrong period. Prevalence is sensitive to whether long-standing cases remain on the source from which counts are drawn. For both measures, a clearly stated and consistently applied case definition is essential, because changes in definition or in how actively cases are sought can move the numbers independently of any real change. This is why epidemiological reporting standards emphasise documenting the data source, the case definition and the ascertainment method together with the measure itself.
The relationship between them
Incidence and prevalence are linked, and the link is intuitive once framed as flow and stock. In broad terms, prevalence reflects both how quickly new cases arise (incidence) and how long cases persist (duration). When a condition lasts a long time, even a modest incidence can produce a high prevalence, because cases accumulate faster than they leave the population through recovery or death. When cases resolve quickly, prevalence stays low even if incidence is high, because cases flow out almost as fast as they arrive. This conceptual relationship explains why the two measures can move in different directions: a change that shortens how long cases persist can lower prevalence even while incidence is unchanged or rising. For that reason the two measures must never be used interchangeably.
Common pitfalls in interpretation
Because the two measures are so often reported side by side, several errors recur. Treating prevalence as if it indicated risk is a frequent mistake: a high prevalence may reflect that cases persist for a long time rather than that the condition arises frequently, so prevalence alone says little about the chance of developing a condition. Comparing an incidence figure from one study with a prevalence figure from another, as though they were the same quantity, produces meaningless conclusions. A further pitfall is failing to define the population at risk consistently; if people who already have the condition are not excluded from the incidence denominator, the calculated incidence will be understated. Finally, both measures are sensitive to how a case is defined and detected: broadening the case definition or improving detection can raise measured incidence or prevalence without any real change in the underlying occurrence, which is why the case definition should always be reported alongside the figure.
When to use which
Use incidence when studying the development of a condition, investigating its causes, or evaluating risk, because it captures the flow of new cases and is the natural measure for cause-and-effect questions. Use prevalence when describing the existing burden, planning services and resources, or characterising how widespread a condition is at a moment in time, because it reflects the total caseload a system must manage. Reporting which measure was used, together with its denominator and time frame, is critical, and reporting guidelines such as STROBE prompt exactly this kind of clarity for observational studies.
Both measures depend on accurate population denominators, which come from a census or population register, underscoring their place in research data infrastructure. The same denominators underpin death rates. Consistent terminology drawn from the CASRAI dictionary helps keep these definitions stable across studies, and authors can consult the guidance for authors when reporting them.
Frequently asked questions
Can incidence be higher than prevalence?
It can, particularly for conditions that resolve quickly. Because prevalence reflects cases that persist, a condition with short duration may show high incidence but low prevalence, since new cases leave the population almost as fast as they arrive and do not accumulate.
Why is the denominator different for each?
Incidence uses the population at risk or person-time, because only those who can newly develop the condition are relevant to counting new cases. Prevalence uses the total population, because it counts all existing cases regardless of when they arose.
Which measure should a study report?
It depends on the question. Studies of causation and risk report incidence; studies of burden, planning and service provision report prevalence. The chosen measure, its denominator and its time frame should always be stated explicitly so readers can interpret it correctly.